Molecule Information
General Information of the Molecule (ID: Mol04310)
| Name |
Ferritin heavy chain (FTH1)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
Cell proliferation-inducing gene 15 protein
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
FTH1
|
||||
| Gene ID | |||||
| Sequence |
MTTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQS
HEEREHAEKLMKLQNQRGGRIFLQDIKKPDCDDWESGLNAMECALHLEKNVNQSLLELH K LATDKNDPHLCDFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGD SD NES Click to Show/Hide
|
||||
| Function |
Stores iron in a soluble, non-toxic, readily available form.Important for iron homeostasis. Has ferroxidase activity. Iron is taken up in the ferrous form and deposited asferric hydroxides after oxidation . Also plays a rolein delivery of iron to cells . Mediates iron uptake incapsule cells of the developing kidney . Delivery tolysosomes is mediated by the cargo receptor NCOA4 for autophagicdegradation and release of iron .{ECO:0000250|UniProtKB:P09528, ECO:0000269|PubMed:24695223,ECO:0000269|PubMed:26436293, ECO:0000269|PubMed:9003196}.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Lung adenocarcinoma [ICD-11: 2C25.0] | [1] | |||
| Resistant Disease | Lung adenocarcinoma [ICD-11: 2C25.0] | |||
| Resistant Drug | Alectinib | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| In Vitro Model | ALK1903 cells | N.A. | Homo sapiens (Human) | N.A. |
| DTP cells | N.A. | Homo sapiens (Human) | N.A. | |
| Experiment for Molecule Alteration |
Western blot assay | |||
| Experiment for Drug Resistance |
CellTiter-Glo 3D cell viability assay | |||
| Mechanism Description | DTP cells evade ALK-TKI-induced ROS-mediated cell death through GPX4 activity. From these data showing elevated levels of ROS that arise through decreased levels of various antioxidant factors and decreased GSH synthesis, it might be expected that ROS-mediated cell death should occur in alectinib-induced DTP cells. However, DTP cells concurrently upregulated GPX4 protein, suggesting that ALK1903 DTP cells are able to evade ROS-mediated cell death by reducing ROS level in a GPX4-dependent manner. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
